Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-EN Version v19-EN
Language English English
Date Updated 2018-06-12 2018-06-12
Drug Identification Number 02232570 02232570
Brand name AIROMIR AIROMIR
Common or Proper name AIROMIR AIROMIR
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients SALBUTAMOL SALBUTAMOL
Strength(s) 100MCG 100MCG
Dosage form(s) METERED-DOSE AEROSOL METERED-DOSE AEROSOL
Route of administration INHALATION INHALATION
Packaging size n/a n/a
ATC code R03AC R03AC
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2018-03-21 2018-03-21
Estimated end date
Actual end date 2018-06-11 2018-06-11
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments